[{"status": "Ongoing", "city": "Kalamazoo", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81838", "recalling_firm": "Torrent Pharma Inc.", "address_1": "1803 Whites Rd Ste 1", "address_2": "", "postal_code": "49008-2883", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0502-2019", "product_description": "LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count bottle (NDC: 13668-409-30), b) 90-count bottle (NDC: 13668-409-90), c) 1000-count bottle (NDC: 13668-409-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda", "product_quantity": "65,832 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181220", "center_classification_date": "20190215", "report_date": "20190227", "code_info": "Count, lots, expiry: [30-count bottle] Lot 4L67C035, exp 10/2019; [90-count bottle] Lot 4L67C035, 4L67C036 exp 10/2019; [1000-count bottle] Lot 4O50C005, exp 11/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68283", "recalling_firm": "Abrams Royal Pharmacy", "address_1": "8220 Abrams Rd", "address_2": "N/A", "postal_code": "75231-1402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Two hospitals in Dallas, TX", "recall_number": "D-0250-2015", "product_description": "Calcium Chloride Preservative Free Sterile injection, 100 mg/ml, 10 ml vial, Rx only, Abrams Royal Compounding Pharmacy, 8220 Abrams Rd, Dallas, TX 75231.", "product_quantity": "1,100 vials", "reason_for_recall": "Non-Sterility: The firm's contract testing laboratory found sterility failures.", "recall_initiation_date": "20130531", "center_classification_date": "20141117", "termination_date": "20160803", "report_date": "20141126", "code_info": "Lot #: 05152013@4 (also written as 051513-4), Exp 11/11/13"}, {"status": "Terminated", "city": "Bellflower", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72361", "recalling_firm": "Pacific Healthcare, Inc dba B&B Pharmacy", "address_1": "10244 Rosecrans Ave", "address_2": "N/A", "postal_code": "90706-2602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and NJ", "recall_number": "D-0179-2016", "product_description": "PAPA/PGE1/PHENTO (35mg/12mcg/1.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "recall_initiation_date": "20151007", "center_classification_date": "20151110", "termination_date": "20160407", "report_date": "20151118", "code_info": "08032015@4, exp 1/30/2016"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0227-2015", "product_description": "VANCOMYCIN, 1mg/0.1mL, injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "12  syringes", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140905@32, discard date: 10/20/2014"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "5 vials", "code_info": "Lot#: 20180205@18, BUD 04/06/2018; 20180126@28, BUD 03/27/2018; 20180126@22, BUD 03/27/2018;  20180205@9, BUD 04/06/2018; 20180214@17, BUD 04/14/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "B-complex (B1-200mg, B2-4mg, B3-200mg,B5-4mg,B6-4mg) /mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0635-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78020", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, IL, CO, LA", "recall_number": "D-1128-2017", "product_description": "Propafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx only, Manufactured By: Watson Pharmaceuticals 311 Bonnie Circle Corona, CA 92880, NDC 63739-509-10", "product_quantity": "3966 unit-dose boxes", "reason_for_recall": "Failed moisture limits: Out of specification for moisture content.", "recall_initiation_date": "20170828", "center_classification_date": "20170906", "termination_date": "20200519", "report_date": "20170913", "code_info": "Lot#: 0112313 Exp. 12/2017; 0113376 Exp. 06/2018; 0113645 Exp. 02/2019."}, {"status": "Terminated", "city": "Stamford", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71732", "recalling_firm": "Purdue Pharma L.P.", "address_1": "201 Tresser Blvd", "address_2": "N/A", "postal_code": "06901-3435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1278-2015", "product_description": "Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch, 30 pouches per carton, Rx only, Distributed by Purdue Pharma L.P. Stamford, CT 06901-3431, NDC 59011-265-30", "product_quantity": "6,264 cartons (30 sublingual tablets in 1 carton)", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20150713", "center_classification_date": "20150721", "termination_date": "20170515", "report_date": "20150729", "code_info": "Lot # 3122833A, Expiry 5/31/16"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0186-2015", "product_description": "DEXPANTHENOL with preservative, 250 mg/mL, injectable, 30 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "210 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140828@14; discard date: 11/26/2014"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1085-2018", "product_description": "Morphine Sulf inhalation, 5mg/3cc, 3cc per vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "60 vials", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NIACIN ER, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs:  CHOLECALCIFEROL, Capsule, 50000 units, NDC 53191036201, Pedigree: AD60268_4, EXP: 5/22/2014;  METAXALONE, Tablet, 800 mg, NDC 64720032110, Pedigree: W003738, EXP: 6/26/2014;  CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: W003716, EXP: 6/26/2014;  C", "address_2": "", "product_quantity": "450 Tablets", "code_info": "NIACIN ER, Tablet, 500 mg has the following codes:   Pedigree: AD60236_4, EXP: 5/22/2014;  Pedigree: W003739, EXP: 6/26/2014;  Pedigree: W003740, EXP: 6/26/2014;  Pedigree: AD73637_1, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIACIN ER, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074307490.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-808-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0248-2017", "product_description": "Ascorbic Acid 500 mg/mL (50 ML). Compounded by Tri-Coast Pharmacy.", "product_quantity": "201 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp Date): 07192016WW (01/15/2017), 07152016G (01/11/2017), 08292016A (02/25/2017), 10262016B (02/28/2017)."}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90653", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1331-2022", "product_description": "FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-327-01.", "product_quantity": "720 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220725", "center_classification_date": "20220809", "termination_date": "20230622", "report_date": "20220817", "code_info": "Lot #: CHI, Exp. Date Dec 22, 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0540-2021", "product_description": "HySept Solution 0.25% Sodium Hypochlorite Solution 473 mL (16 fl. oz.) NDC 39328-063-25 Manufactured in USA Patrin Pharma, Skokie, IL 60076", "product_quantity": "236 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Bennet", "state": "NE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95503", "recalling_firm": "Staska Pharmaceuticals, Inc.", "address_1": "742 Evergreen Dr", "address_2": "N/A", "postal_code": "68317-2365", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0040-2025", "product_description": "Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317", "product_quantity": "4773 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of glass particulates.", "recall_initiation_date": "20240930", "center_classification_date": "20241107", "termination_date": "20250805", "report_date": "20241113", "code_info": "Lot #SP2400058, Exp 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64198", "recalling_firm": "Pacira Pharmaceuticals, Inc.", "address_1": "10450 Science Center Dr", "address_2": "N/A", "postal_code": "92121-1119", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.", "recall_number": "D-168-2013", "product_description": "EXPAREL (bupivacaine liposome injectable suspension),  1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA", "product_quantity": "324 vials", "reason_for_recall": "Subpotent; bupivacaine", "recall_initiation_date": "20121217", "center_classification_date": "20130225", "termination_date": "20130503", "report_date": "20130306", "code_info": "Lot #11-2005  Control #23542  Manufacture Date: 05Dec11  2011-L-009"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0713-2021", "product_description": "MORPHINE-BUPIVACAINE-KETAMINE PF INJECTABLE 21 mL syringe in two strengths: a) 5MG-25MG-5MG/ML, b) 1MG-2MG-100MCG/ML, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09302020@31, BUD 10/28/2020, b) 09302020@29, BUD 10/30/2020"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1612-2020", "product_description": "WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 Tablets, NDC 64727-6150-4; c) 60 Tablets, NDC 64727-6150-5; d) 90 Tablets, NDC 64727-6150-6; e) 100 Tablets, NDC 64727-6150-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0716-2020", "product_description": "BUP 675MCG/MORP 20MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@12 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73899", "recalling_firm": "Baptist Health Medical Towers Pharmacy and Infusion Services", "address_1": "9601 Baptist Health Dr Ste 109", "address_2": "N/A", "postal_code": "72205-6323", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Arkansas", "recall_number": "D-0932-2016", "product_description": "Nafcillin 12 grams in 322 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR", "product_quantity": "11 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20160418", "center_classification_date": "20160529", "termination_date": "20161223", "report_date": "20160608", "code_info": "All product remaining within expiry"}, {"country": "United States", "city": "Plainsboro", "address_1": "666 Plainsboro Rd", "reason_for_recall": "CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.", "address_2": "Bldg 200  Ste 230", "product_quantity": "9695 bottles", "code_info": "Lot BLM715A, Jul-19", "center_classification_date": "20190321", "distribution_pattern": "NJ, NY, FL", "state": "NJ", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90 count bottles, Rx Only, Manufactured for:  Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by:  Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India.  NDC 33342-0052-10", "report_date": "20190327", "classification": "Class II", "openfda": {}, "recalling_firm": "Macleods Pharma Usa Inc", "recall_number": "D-1040-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "82147", "termination_date": "20200928", "recall_initiation_date": "20190221", "postal_code": "08536-3030", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0193-2015", "product_description": "GENTAMICIN SULFATE, 480mg/1000mL, solution for irrigation, 300 mL plastic bottle, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "300 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140912@29/150, discard date: 10/16/2014"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0409-2020", "product_description": "CVS Health Lubricant Eye Drops Lasting Dry Eye Relief, Twin Pack, Item#: 495323, Product Size: 2 x 10 mL, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "37656 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17291 9/19   17385 12/19   18118 5/20"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0208-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 30 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "5 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06252021:69 BUD: 10/23/2021; 08272021:62 BUD: 02/08/2022", "more_code_info": ""}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029307 Exp. 11/14/2019,    10029939 Exp. 11/20/2019,      10029884 Exp. 11/19/2019,    10029915 Exp. 11/20/2019,    10030385 Exp. 11/25/2019,    10030386 Exp. 11/25/2019,  10030923 Exp. 12/11/2019,      10031320 Exp. 12/11/2019,  10031025 Exp. 12/12/2019,    10031024 Exp. 12/12/2019,    10032678 Exp. 1/8/2020,    10032993 Exp. 1/14/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.2% 400 mg/200 mL (2 mg/mL) in 0.9% Sodium Chloride 200 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1440-76", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0554-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88884", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0258-2022", "product_description": "Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 52565-002-05", "product_quantity": "2664 bottles", "reason_for_recall": "Defective Container", "recall_initiation_date": "20211019", "center_classification_date": "20211123", "termination_date": "20240618", "report_date": "20211201", "code_info": "Lot #: 15188, Exp 2/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0335-2018", "product_description": "TAD Glutathione Whitening Kits lyophilized powder for injection, 600 mg vials, 10 vials + 10 amps x 4 mL, Manufactured by: Biomedica Foscama Industria, Ferentino, Italy", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87373", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0295-2021", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Contains: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL, 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5554-3.", "product_quantity": "786,900 patches", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel.", "recall_initiation_date": "20210219", "center_classification_date": "20210303", "termination_date": "20240705", "report_date": "20210310", "code_info": "Lots #: 87580, Exp 4/2021, 87819, Exp 4/2021, 88244, Exp 6/2021, 88245, Exp 6/2021, 88532, Exp 06/2021 & 88533, Exp 7/2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94461", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0464-2024", "product_description": "FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.", "product_quantity": "4648 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.", "recall_initiation_date": "20240419", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot 14842, Exp. 6/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-941-2015", "product_description": "Trehalose Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Tempe", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96735", "recalling_firm": "SAINI TRADE INC", "address_1": "1405 N Scottsdale Rd", "address_2": "", "postal_code": "85288-1714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0467-2025", "product_description": "Male Ultra Pro, Unleash Your Force 2, 10 capsules per box, Distributed by: Health Fixer Tempe AZ 85288, UPC B0CZN7C6YH.", "product_quantity": "300 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.", "recall_initiation_date": "20250414", "center_classification_date": "20250611", "report_date": "20250618", "code_info": "All lots Lot #: KT-1ST-43-0110/2025, Exp. 03/15/2026", "more_code_info": ""}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C238 BUD: 11/14/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 25mg pellet, 1 count (NDC 69761-025-01), 6 count (NDC 69761-025-06), 12 count (NDC 69761-025-12), and 30 count (NDC 69761-025-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0229-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077272"], "brand_name": ["CARBAMAZEPINE"], "generic_name": ["CARBAMAZEPINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-268", "13668-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBAMAZEPINE"], "rxcui": ["308973", "308979"], "spl_id": ["2b305f64-7c1a-4cf6-a4ad-57326eb4c874"], "spl_set_id": ["97e6e175-75e8-437b-b457-ddb1ae4e857d"], "package_ndc": ["13668-268-30", "13668-268-01", "13668-268-10", "13668-268-31", "13668-268-05", "13668-271-01", "13668-271-10", "13668-271-49", "13668-271-05"], "is_original_packager": [true], "upc": ["0313668268300"], "nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "unii": ["33CM23913M"]}, "product_type": "Drugs", "event_id": "85644", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1317-2020", "product_description": "Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05", "product_quantity": "6228 Bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20200511", "center_classification_date": "20200618", "termination_date": "20220810", "report_date": "20200610", "code_info": "Lot #:  4FF4F001, Exp 1/2023"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75757", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0233-2017", "product_description": "Kids' Relief Ear Relief Oral Liquid 0.85 fl oz. (25 mL)  3025 de'l Assomption Blvd. Montreal, QC H1N 2H2 Canada   NDC 60512-913-8 UPC 77815909639", "product_quantity": "22,704 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161118", "center_classification_date": "20161223", "termination_date": "20200108", "report_date": "20170104", "code_info": "Lot # 35254; Exp. 05/20"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0944-2022", "product_description": "PGE-3 Alprostadil 150 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0030-10.", "product_quantity": "421 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: L24508 BUD: 12/8/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["72789-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["3143f509-5529-ee8b-e063-6294a90aeed3"], "spl_set_id": ["14f3091c-f243-4364-b433-727c7d4ef8d5"], "package_ndc": ["72789-009-30", "72789-009-60", "72789-009-90", "72789-009-93", "49483-0623-01"], "original_packager_product_ndc": ["49483-623"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85828", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "United States.", "recall_number": "D-1333-2020", "product_description": "metFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90 tablets (NDC 72789-009-90); d) 180 tablets (NDC 72789-009-93); e) 100 tablets (NDC 49483-0623-01)  bottles, Rx only PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127", "product_quantity": "1969 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200605", "center_classification_date": "20200620", "termination_date": "20211108", "report_date": "20200701", "code_info": "Lots:  a) A20B02, I19D03, J19A98, K19E32, L19C86 Exp. 12/31/2020;     b) I19D55, I19F50, K19A18, K19D87, L19B34, L19D23, L19E74 Exp. 12/31/2020;     c) I19E91, I19F33, J19B88, J19E70, K19D26, L19A65 Exp. 12/31/2020;     d) I19C21 Exp. 08/21/2020, I19C57, J19C21, J19C67, K19B53, L19C77, L19E44 Exp. 12/31/2020;     e) XP9004 Exp. 12/31/2020"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1013-2016", "product_description": "TESTOSTERONE CYPIONATE  150MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01042016:26@3, Exp.04/03/2016; Lot #: 01072016: 10@15, Exp.04/06/2016; Lot #: 02032016:41@16, Exp. 05/03/2016; Lot #: 03152016: 62@44, Exp.06/15/2016; Lot #: 04292016:35@11, Exp. 07/31/2016."}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0367-2016", "product_description": "Magnesium Chloride Hexahydrate Injection 200mg/mL, 50mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "289 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1162-2020", "product_description": "Sperm Booster, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Philadelphia", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71836", "recalling_firm": "Mutual Pharmaceutical Company,  Inc.", "address_1": "1100 Orthodox St", "address_2": "N/A", "postal_code": "19124-3168", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1424-2015", "product_description": "Imipramine HCl Tablets, USP, 25 mg, 100 count bottles, Mfd By: Mutual Pharmaceutical Co., Inc., Philadelphia, PA --- NDC 54738-913-01", "product_quantity": "14,112 bottles", "reason_for_recall": "Chemical Contamination; benzophenone leached from the product label varnish", "recall_initiation_date": "20150716", "center_classification_date": "20150909", "termination_date": "20161013", "report_date": "20150916", "code_info": "lot #s: 6655001, exp 8/16, 6679801, exp 2/17, 6690302, exp 4/17 and 6706001, exp 7/17"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0151-2015", "product_description": "Tri-mix, 30 mg/2 mg/20 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "260 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06272014@52, Exp 9/25/2014; 07112014@40, Exp 9/30/2014; 07252014@32, Exp 10/23/2014; 08192014@24, Exp 11/17/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0765-2020", "product_description": "QUADMIX FORTE in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 08132019@15 Exp. 02/09/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "77466", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within US", "recall_number": "D-0923-2017", "product_description": "Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186.  NDC: 68968-6610-8", "product_quantity": "14434 cartons", "reason_for_recall": "Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.", "recall_initiation_date": "20170427", "center_classification_date": "20170623", "termination_date": "20190311", "report_date": "20170705", "code_info": "Lot #:: 78618, Exp. 05/2017"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201089"], "brand_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "generic_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0397", "0591-0398"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICLOFENAC SODIUM", "MISOPROSTOL"], "rxcui": ["857706", "1359105"], "spl_id": ["03f24a4c-0fe7-446a-b64d-a7c6b12cae0f"], "spl_set_id": ["df8b8660-0c24-4848-8bea-c1b935090c66"], "package_ndc": ["0591-0397-19", "0591-0397-60", "0591-0398-60"], "is_original_packager": [true], "nui": ["N0000175785", "M0017811"], "pharm_class_epc": ["Prostaglandin E1 Analog [EPC]"], "pharm_class_cs": ["Prostaglandins E, Synthetic [CS]"], "unii": ["0E43V0BB57", "QTG126297Q"], "upc": ["305910398606"]}, "product_type": "Drugs", "event_id": "67259", "recalling_firm": "Watson Laboratories, Inc.-(Actavis) - Florida", "address_1": "4955 Orange Dr", "address_2": "N/A", "postal_code": "33314-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1082-2014", "product_description": "Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.", "product_quantity": "5987 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.", "recall_initiation_date": "20131220", "center_classification_date": "20140207", "termination_date": "20140917", "report_date": "20140219", "code_info": "Lot# 605957A, Exp 09/14"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1113-2016", "product_description": "All phenylephrine Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92376", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0763-2023", "product_description": "Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  NDC:  25021-140-10", "product_quantity": "2,249,980 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230519", "center_classification_date": "20230523", "report_date": "20230531", "code_info": "Lots: NFL101, NFL102, EXP: 1/31/2024; Lots: NFL103, NFL104, EXP: 5/31/2024; Lot: NFL201, EXP: 03/31/2025; Lot: NFL202, EXP: 5/31/2025;"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0983-2019", "product_description": "Dr. King's Natural Medicine Regional Allergies Hawaii U.S. Homeopathic, 2 fl oz (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955520620, NDC 57955-5206-2", "product_quantity": "194 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 050216M Exp. 05/19; 070516A Exp. 07/19"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry.", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Dexamethasone Sodium Phosphate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0845-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bayside", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "74144", "recalling_firm": "SOS Telecom Inc.", "address_1": "20228 45th Ave", "address_2": "N/A", "postal_code": "11361-2540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NY", "recall_number": "D-0101-2017", "product_description": "Tiger-X, 1200 mg, 1 capsule per pack , 24 single packs per box", "product_quantity": "N/A", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements", "recall_initiation_date": "20160512", "center_classification_date": "20161014", "termination_date": "20180706", "report_date": "20161026", "code_info": "Lot No: 9236999; Best use by: 12/16/2016"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82615", "recalling_firm": "Customceutical Compounding", "address_1": "4611 E Shea Blvd Bldg 3 Ste 180", "address_2": "N/A", "postal_code": "85028-4258", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1262-2019", "product_description": "TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostadil 7 mcg/mL), 2 mL multidose MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272", "product_quantity": "N/A", "reason_for_recall": "Lack of assurance of sterility for injectables and solutions intended to be sterile.", "recall_initiation_date": "20190408", "center_classification_date": "20190430", "termination_date": "20230519", "report_date": "20190508", "code_info": "Lot #: 02182019@22, Exp 8/02/19"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-025-2013", "product_description": "Up&Up Psyllium Fiber Supplement, 100% natural psyllium husk, Fiber Therapy for Regularity/Fiber Supplement, 160 capsules per bottle,  Distributed by: Target Corp., Minneapolis, MN 55403, Made in USA,  NDC 11673-059-87, UPC 3-68163-11926-8.", "product_quantity": "48,120 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Item 119160TGT; Lots15952, Exp 06/15; 16459, 16460, 16463, Exp 07/15; 16475, Exp 08/15"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "429 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  02252015@1, 5/26/2015; 03062015@38, 6/4/2015; 03162015@77, 6/14/2015; 03242015@44, 6/22/2015; 03242015@51, 6/22/2015; 04072015@58, 7/6/2015; 04132015@6, 6/12/2015; 04142015@60, 6/13/2015; 04222015@12, 6/21/2015; 05122015@16, 7/11/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 10 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1585-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Fort Myers", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89356", "recalling_firm": "Medique Products", "address_1": "17080 Alico Commerce Ct Ste 1", "address_2": "N/A", "postal_code": "33967-8509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0391-2022", "product_description": "Extra Strength Headache (acetaminophen 250 mg, aspirin 250 mg, caffeine 65 mg) tablets, packaged in 2-count tablets per packet, Manufactured for: Lil' Drug Store Products, Inc., Cedar Rapids, IA 52404", "product_quantity": "6,639,838 tablets", "reason_for_recall": "CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.", "recall_initiation_date": "20211206", "center_classification_date": "20220120", "termination_date": "20230621", "report_date": "20220126", "code_info": "Lots: 6492 Exp. 06/2022; 6701 Exp. 10/2022; 6750 Exp. 12/2022; 6853 Exp. 01/2023; 6854 Exp. 01/2023; 6869 Exp. 02/2023; 6898 Exp. 02/2023; 6901 Exp. 02/2023; 7059 Exp. 05/2023; 7060 Exp. 05/2023; 7064 Exp. 06/2023; 7065 Exp. 06/2023"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0768-2019", "product_description": "Dr. King's SafeCare Rx ParaClenz, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955001621, NDC 57955-0193-2", "product_quantity": "795 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 081015J Exp. 08/18; 062816A Exp. 06/19; 101716B Exp. 10/19; 030718A Exp. 03/20"}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210931"], "brand_name": ["BUSULFAN"], "generic_name": ["BUSULFAN"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-210"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["BUSULFAN"], "rxcui": ["253113"], "spl_id": ["ae29e15b-df07-403f-8d07-f99e3ce501e7"], "spl_set_id": ["4049d57f-342e-4233-8292-fed6b8f128ec"], "package_ndc": ["72485-210-01", "72485-210-08"], "is_original_packager": [true], "upc": ["0372485210015"], "nui": ["N0000000236", "N0000175558"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "unii": ["G1LN9045DK"]}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0121-2021", "product_description": "Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.", "product_quantity": "2,064 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #: 7S10008B, Exp. 12/31/2020"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0909-2022", "product_description": "T-105 Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL, Packaged as a) 2.5 mL Multi-Dose vial NDC 73198-0005-03; b) 5 mL Multi Dose vial, NDC 73198-0005-05, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "3312 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: K41J09, K41I09 BUD: 11/9/2022; B24B22-22 BUD: 2/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-508-2015", "product_description": "Alpha Chymotrypsin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Apache Junction", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90067", "recalling_firm": "Torco Race Fuels", "address_1": "2527 W Dallas Ave", "address_2": "", "postal_code": "85120-4400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in the USA", "recall_number": "D-0786-2022", "product_description": "TORCO RACING FUELS HAND SANITIZER, Alcohol Antiseptic 80% Topical Solution, Hand Sanitizer Non-Sterile Solution, FDA Approved,  76590-8347-1, 3780 mL, 3.78 Liters (1 Gallon). Torco Race Fuels 2527 W. Dallas Ave. Apache Junction, AZ, 85120", "product_quantity": "127 gallons", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20220421", "center_classification_date": "20220425", "termination_date": "20240812", "report_date": "20220504", "code_info": "No lot or Expiration date on Product", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DOXYCYCLINE MONOHYDRATE Capsule, 100 mg may be potentially mislabeled as     diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: AD67992_4, EXP: 5/28/2014;  DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD52778_4, EXP: 5/20/2014.", "address_2": "", "product_quantity": "799 Capsules", "code_info": "DOXYCYCLINE MONOHYDRATE, Capsule, 100 mg has the following codes    Pedigree: AD65323_7, EXP: 5/28/2014;  Pedigree: AD52778_25, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXYCYCLINE MONOHYDRATE Capsule, 100 mg, Rx only,  Distributed by: AidaPak Service, LLC, NDC 49884072703", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-588-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #:  0388007", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYPERTONIC SOLUTION IN PRESERVED WATER 10% INJECTABLE 50 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1545-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-316-2014", "product_description": "Triamcinolone 40mg PF 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2164 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050141"], "brand_name": ["BICILLIN L-A"], "generic_name": ["PENICILLIN G BENZATHINE"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-700", "60793-701", "60793-702"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PENICILLIN G BENZATHINE"], "rxcui": ["731564", "731566", "731567", "731568", "731570", "731571"], "spl_id": ["4b3694af-9d77-487f-8838-b75aec6636da"], "spl_set_id": ["012d46f1-d0a0-4676-a879-cd320297ab16"], "package_ndc": ["60793-700-01", "60793-700-10", "60793-701-02", "60793-701-10", "60793-702-04", "60793-702-10"], "is_original_packager": [true], "unii": ["RIT82F58GK"]}, "product_type": "Drugs", "event_id": "97220", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0545-2025", "product_description": "Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04", "product_quantity": "19,279 vials", "reason_for_recall": "CGMP Deviations; particulates identified during visual inspection", "recall_initiation_date": "20250710", "center_classification_date": "20250730", "report_date": "20250806", "code_info": "Lots GT2598, GT2599, Exp 09/30/26; HK2909, Exp 02/28/27; HR9969, Exp 04/30/27;  HR9984, Exp 08/31/27.", "more_code_info": ""}, {"status": "Terminated", "city": "Hendersonville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83997", "recalling_firm": "Basic Reset Inc.", "address_1": "260 W Main St Ste 103", "address_2": "N/A", "postal_code": "37075-7316", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and U.S. Virgin Islands, Canada, Nigeria, United Kingdom, Australia, Israel, Hungary, UAE, Mexico, Philippines, Greece", "recall_number": "D-0195-2020", "product_description": "BIOGENYX True Full Spectrum CBD Oil Wintergreen, 1 fl. oz. (30 mL) bottle, 750 mg, Distributed by: Biogenyx, Inc. Hendersonville, TN 37075", "product_quantity": "25 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA", "recall_initiation_date": "20191018", "center_classification_date": "20191105", "termination_date": "20211027", "report_date": "20191113", "code_info": "Lots: 1902411.25"}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83190", "recalling_firm": "Pharma-Natural Inc.", "address_1": "14500 Nw 60th Ave Bldg 7f", "address_2": "N/A", "postal_code": "33014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-1501-2019", "product_description": "Lido E.R. (Lidocaine HCL 4%) Pain Relieving Topical Analgesic Cream, 4 oz (113 g) jar, Distributed by Diabetic Supply of Suncoast, Inc., P.O. Box 2102, Vega Alta, PR 00692, NDC 63788-115-04.", "product_quantity": "1070 jars", "reason_for_recall": "CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.", "recall_initiation_date": "20190621", "center_classification_date": "20190723", "termination_date": "20211027", "report_date": "20190731", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "67 ml", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@7, 5/31/2015; 03202015@59, 6/18/2015; 04172015@39, 6/16/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 60 mg/ml + Fentanyl 7,500 mcg/ml + Bupivacaine 30 mg/ml + Clonidine 1,100 mcg/ml + Baclofen 600 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1679-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72192", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W. Field Court, Suite 300", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-0231-2016", "product_description": "RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.", "product_quantity": "6861 Vials", "reason_for_recall": "Failed Impurity/Degradation Specifications:  Out of Specifications result obtained for a known impurity.", "recall_initiation_date": "20150820", "center_classification_date": "20151113", "termination_date": "20170126", "report_date": "20151125", "code_info": "Lot #: 14RIF1(A), Expiry: 9/30/2016."}, {"status": "Terminated", "city": "Cleveland", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85217", "recalling_firm": "Medical Center Pharmacy, Inc.", "address_1": "2401 N Ocoee St", "address_2": "N/A", "postal_code": "37311-3853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Specific prescriptions to patients in TN", "recall_number": "D-1077-2020", "product_description": "*Mitomycin 0.04% Ophth DR eye drops, 5 mL bottle, Rx only,  Medical Center Pharmacy, 2401 N. Ocoee Street, Cleveland, TN 37311, NDC 67457-0518-05.", "product_quantity": "2 bottles", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20200313", "center_classification_date": "20200401", "termination_date": "20221014", "report_date": "20200408", "code_info": "Lot: 03022020@5 BUD: 03/16/2020"}, {"status": "Terminated", "city": "Celaya", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86858", "recalling_firm": "Simex Logistics SA de CV", "address_1": "Calle Salvatierra Fracc. El Puente 101", "address_2": "Col. Santa Maria, Celaya", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA, NV, TX", "recall_number": "D-0162-2021", "product_description": "Health & Hand Gel Hand Sanitizer 70% Alcohol Content, 33.8 FL OZ (1L), Distributed By Blue Ridge Southern Supply, LLC 1130 Ada St. Blue Ridge, GA 30513 Produced By: Simex Logistics S.A. de C.V. Salvatierra No. 101 Fracc. El Puente C.P. 38040 Celaya, Guanajuato, Mexico. smxcontact@simex-logistics.com Barcode: 6 18149 21988 9", "product_quantity": "19008 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20201125", "center_classification_date": "20201216", "termination_date": "20230517", "report_date": "20201223", "code_info": "Lot: 0-720, Exp 05/16/2023"}, {"country": "United States", "city": "Orchard Park", "address_1": "707 Sterling Drive", "reason_for_recall": "Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.", "address_2": "", "product_quantity": "", "code_info": "Stock No: 1074; Case UPC: 3 10742 81074 (5); Item UPC 3 10742  01074 9", "center_classification_date": "20140128", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "ROHTO Redness Relief, Cool, Redness Reliever, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL).  UPC 3 10742  01074 9,  Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127.   Made in Vietnam.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "The Mentholatum Co.", "recall_number": "D-1041-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "67314", "termination_date": "20180601", "more_code_info": "", "recall_initiation_date": "20140116", "postal_code": "14127", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1504-2014", "product_description": "Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg*/25 mg 30 count bottles, Rx Only  Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-116-30", "product_quantity": "", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #211836 Exp - 11/30/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1086-2018", "product_description": "Dehydrated Alcohol Solution, packaged in a) 1 mL and b) 3 mL vials, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "a) 2 vials; b) 1 vial", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021897"], "brand_name": ["VIVITROL"], "generic_name": ["NALTREXONE"], "manufacturer_name": ["Alkermes, Inc."], "product_ndc": ["65757-300", "65757-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["637213", "637216"], "spl_id": ["908a42b5-e168-42ca-9421-0f5f2288b7e2"], "spl_set_id": ["cd11c435-b0f0-4bb9-ae78-60f101f3703f"], "package_ndc": ["65757-300-01", "65757-302-02", "65757-304-03", "65757-301-01", "65757-303-02", "65757-305-03"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "67838", "recalling_firm": "Alkermes, Inc.", "address_1": "852 Winter St", "address_2": "N/A", "postal_code": "02451-1420", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1556-2014", "product_description": "VIVITROL (naltrexone for extended-release injectable suspension);  380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.", "product_quantity": "4,364 vials", "reason_for_recall": "Customer complaints for failure to deliver the dose.", "recall_initiation_date": "20140304", "center_classification_date": "20140822", "termination_date": "20141222", "report_date": "20140903", "code_info": "Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01."}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-455-2013", "product_description": "Bimix Inj 30:1 MDV: 5ml, 10 ml, 3x10ml, 2x10ml  Penile Injection, 30 and 90 day expiration,", "product_quantity": "128", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "62999", "recalling_firm": "Hospira Inc.", "address_1": "375 N Field Dr", "address_2": "N/A", "postal_code": "60045-2513", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1672-2012", "product_description": "Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24", "product_quantity": "56,420 vials", "reason_for_recall": "Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.", "recall_initiation_date": "20120803", "center_classification_date": "20120830", "termination_date": "20140506", "report_date": "20120905", "code_info": "07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206919"], "brand_name": ["LEVOFLOXACIN"], "generic_name": ["LEVOFLOXACIN IN 5% DEXTROSE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-243", "55150-244", "55150-245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVOFLOXACIN"], "rxcui": ["1665497", "1665507", "1665515"], "spl_id": ["8cb7f273-fc11-48e7-b2ef-a5290ab7ac4e"], "spl_set_id": ["7d3f83bf-2db7-4657-9538-406adf321ad5"], "package_ndc": ["55150-243-46", "55150-244-47", "55150-245-52"], "is_original_packager": [true], "upc": ["0355150244478"], "nui": ["N0000193223", "M0372253"], "pharm_class_epc": ["Fluoroquinolone Antibacterial [EPC]"], "pharm_class_cs": ["Fluoroquinolones [CS]"], "unii": ["6GNT3Y5LMF"]}, "product_type": "Drugs", "event_id": "79772", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0708-2018", "product_description": "Levofloxacin in 5% Dextrose Injection, 500 mg Levofloxacin (5 mg/mL) in 100 mL of 5% Dextrose, For Intravenous Infusion, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured for AuroMedics Pharma, LLC, NDC 55150-244-47", "product_quantity": "308472 bags", "reason_for_recall": "Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap", "recall_initiation_date": "20180327", "center_classification_date": "20180503", "termination_date": "20220218", "report_date": "20180509", "code_info": "Lot/Batch #'s:    CLF160008, CLF160009, CLF160010, CLF160011, exp June 2018; CLF160015, CLF160016 , CLF160017, exp August 2018; CLF170001 exp December 2018; CLF170023, CLF170024, exp May 2019; CLF170039, CLF170040, CLF170041, CLF170042, CLF170043, CLF170044, CLF170045, CLF170046, CLF170047 exp August 2019"}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0017-2026", "product_description": "Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "141,984 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026 Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Bartow", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64409", "recalling_firm": "OLAAX International", "address_1": "6105 Riverlake Blvd", "address_2": "N/A", "postal_code": "33830-7754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide, Puerto Rico and  Venezuela and Bolivia", "recall_number": "D-600-2013", "product_description": "MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL", "product_quantity": "600 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.", "recall_initiation_date": "20130212", "center_classification_date": "20130613", "termination_date": "20191001", "report_date": "20130619", "code_info": "All Lots"}, {"status": "Terminated", "city": "Billerica", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA079157"], "brand_name": ["KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI"], "generic_name": ["TECHNETIUM TC-99M SESTAMIBI"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["45567-0555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TECHNETIUM TC-99M SESTAMIBI"], "spl_id": ["21ca8de4-28b7-425f-e063-6394a90a3340"], "spl_set_id": ["e545ac6a-83dc-485a-8bb4-c0b9d8f3d144"], "package_ndc": ["45567-0555-1", "45567-0555-2"], "is_original_packager": [true], "nui": ["N0000177914", "N0000000205"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "unii": ["971Z4W1S09"]}, "product_type": "Drugs", "event_id": "65244", "recalling_firm": "Pharmalucence, Inc.", "address_1": "29 Dunham Rd", "address_2": "N/A", "postal_code": "01821", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide & Bahamas, Barbados, Bermuda, Japan", "recall_number": "D-808-2013", "product_description": "Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2,  Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821", "product_quantity": "17,260 vials", "reason_for_recall": "Presence of Particulate Matter; particulate found in retain samples", "recall_initiation_date": "20130530", "center_classification_date": "20130719", "termination_date": "20131017", "report_date": "20130731", "code_info": "Lot 280011, Exp 08/13", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["42641d19-c870-7770-e063-6294a90acf97"], "spl_set_id": ["8529596f-37e4-c44e-e053-2a91aa0ad014"], "package_ndc": ["54365-400-32"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0347-2021", "product_description": "BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.10 fl. oz. (3 ml) each, 25 Applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-32 REF 930400", "product_quantity": "24,969,700 cartons", "reason_for_recall": "Lack of Assurance of Sterility:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0010759, 11/30/2022;  0025045, 11/30/2022;  0035136, 12/31/2022;  0054691, 2/28/2023;  0057018, 2/28/2023;  0058944, 2/28/2023;  0062656, 2/28/2023;  0063728, 2/28/2023;  0063740, 2/28/2023;  0064594, 2/28/2023;  0065288, 2/28/2023;  0066368, 2/28/2023;  0067288, 3/31/2023;  0069106, 3/31/2023;  0070865, 3/31/2023;  0071359, 3/31/2023;  0072872, 3/31/2023;  0073232, 3/31/2023;  0076029, 3/31/2023;  0077515, 3/31/2023;  0077519, 3/31/2023;  0078347, 3/31/2023;  0079853, 3/31/2023;  0080632, 3/31/2023;  0081061, 3/31/2023;  0081062, 3/31/2023;  0084750, 3/31/2023;  0084754, 3/31/2023;  0084758, 3/31/2023;  0085418, 3/31/2023;  0088774, 3/31/2023;  0090545, 3/31/2023;  0090949, 3/31/2023;  0091664, 3/31/2023;  0092927, 3/31/2023;  0093445, 3/31/2023;  0094039, 3/31/2023;  0005878, 3/31/2023;  0097559, 3/31/2023;  0098525, 3/31/2023;  0099419, 2/28/2023;  0099421, 3/31/2023;  0100379, 3/31/2023;  0105130, 3/31/2023;  0105985, 3/31/2023;  0106926, 4/30/2023;  0106937, 4/30/2023;  0111775, 4/30/2023;  0112982, 4/30/2023;  0113301, 4/30/2023;  0113433, 4/30/2023;  0114091, 4/30/2023;  0114101, 4/30/2023;  0115679, 4/30/2023;  0118820, 4/30/2023;  0119488, 4/30/2023;  0120668, 4/30/2023;  0121257, 4/30/2023;  0121281, 4/30/2023;  0122195, 4/30/2023;  0125774, 4/30/2023;  0126308, 4/30/2023;  0127006, 4/30/2023;  0127856, 4/30/2023;  0128820, 4/30/2023;  0129413, 4/30/2023;  0132806, 4/30/2023;  0132808, 4/30/2023;  0133318, 4/30/2023;  0135284, 4/30/2023;  0136179, 4/30/2023;  0136919, 4/30/2023;  0139776, 4/30/2023;  0139779, 4/30/2023;  0140050, 4/30/2023;  0141253, 4/30/2023;  0142167, 4/30/2023;  0143703, 4/30/2023;  0148151, 4/30/2023;  0149875, 5/31/2023;  0153587, 5/31/2023;  0154180, 5/31/2023;  0154183, 5/31/2023;  0155301, 5/31/2023;  0155611, 5/31/2023;  0156437, 5/31/2023;  0156782, 5/31/2023;  0157078, 5/31/2023;  0160601, 5/31/2023;  0161218, 5/31/2023;  0162594, 5/31/2023;  0162595, 5/31/2023;  0163255, 5/31/2023;  0164591, 6/30/2023;  0167383, 6/30/2023;  0168035, 6/30/2023;  0168225, 6/30/2023;  0169563, 6/30/2023;  0169624, 6/30/2023;  0170815, 6/30/2023;  0171463, 6/30/2023;  0171467, 6/30/2023;  0174318, 6/30/2023;  0174321, 6/30/2023;  0174763, 6/30/2023;  0176737, 6/30/2023;  0177382, 6/30/2023;  0178582, 6/30/2023;  0178584, 6/30/2023;  0188425, 6/30/2023;  0189107, 6/30/2023;  0190185, 6/30/2023;  0192851, 6/30/2023;  0197378, 6/30/2023;  0197837, 6/30/2023;  0198823, 7/31/2023;  0199710, 7/31/2023;  0199720, 6/30/2023;  0199721, 6/30/2023;  0202925, 7/31/2023;  0203832, 6/30/2023;  0204881, 6/30/2023;  0205329, 6/30/2023;  0205331, 6/30/2023;  0206178, 7/31/2023;  0206188, 7/31/2023;  0208782, 7/31/2023;  0209285, 7/31/2023;  0210048, 7/31/2023;  0210638, 7/31/2023;  0211069, 7/31/2023;  0212509, 7/31/2023;  0212627, 7/31/2023;  0213661, 7/31/2023;  0216135, 7/31/2023;  0216992, 7/31/2023;  0216995, 7/31/2023;  0225098, 7/31/2023;  0225257, 7/31/2023;  0226610, 7/31/2023;  0227802, 7/31/2023;  0227838, 7/31/2023;  0228011, 7/31/2023;  0229538, 7/31/2023;  0230050, 7/31/2023;  0230194, 7/31/2023;  0231645, 7/31/2023;  0231646, 7/31/2023;  0232170, 7/31/2023;  0232171, 7/31/2023;  0233607, 7/31/2023;  0233609, 7/31/2023;  0234326, 7/31/2023;  0236941, 8/31/2023;  0237345, 8/31/2023;  0238657, 8/31/2023;  0238658, 8/31/2023;  0239736, 8/31/2023;  0240258, 8/31/2023;  0240259, 8/31/2023;  0241313, 8/31/2023;  0241656, 8/31/2023;  0242880, 8/31/2023;  0244660, 8/31/2023;  0244662, 8/31/2023;  0245775, 7/31/2023;  0246170, 8/31/2023;  0246478, 8/31/2023;  0247206, 8/31/2023;  0248555, 8/31/2023;  0248737, 7/31/2023;  0252884, 8/31/2023;  0253778, 8/31/2023;  0253810, 8/31/2023;  0254567, 8/31/2023;  0254731, 8/31/2023;  0255645, 8/31/2023;  0258252, 8/31/2023;  0258659, 8/31/2023;  0259065, 9/30/2023;  0259898, 9/30/2023;  0260681, 9/30/2023;  0261975, 9/30/2023;  0262729, 9/30/2023;  0265184, 9/30/2023;  0279818, 9/30/2023;  0308327, 10/31/2023;  0309811, 10/31/2023;  0309816, 10/31/2023;  0311453, 10/31/2023;  0312698, 10/31/2023;  0314634, 10/31/2023;  0315662, 10/31/2023;  0316151, 11/30/2023;  0316372, 10/31/2023;  0317672, 11/30/2023;  0318148, 11/30/2023;  0321438, 11/30/2023;  0322315, 11/30/2023;  0323068, 11/30/2023;  0323448, 11/30/2023;  0323503, 11/30/2023;  0324263, 11/30/2023;  0324264, 11/30/2023;  0328929, 11/30/2023;  0329153, 11/30/2023;  0329996, 11/30/2023;  0330665, 11/30/2023;  0335120, 11/30/2023;  0335799, 11/30/2023;  0337020, 11/30/2023;  0338067, 11/30/2023;  0338974, 11/30/2023;  0340677, 11/30/2023;  0343589, 11/30/2023;  0343898, 11/30/2023;  0343903, 11/30/2023;  0344397, 12/31/2023;  0345866, 11/30/2023;  0345870, 11/30/2023;  0346321, 12/31/2023;  0349906, 12/31/2023;  0349907, 12/31/2023;  0350058, 12/31/2023;  0350772, 12/31/2023;  0351193, 12/31/2023;  0351226, 12/31/2023;  0351821, 12/31/2023;  0352445, 11/30/2023;  0352694, 11/30/2023;  0353338, 12/31/2023;  0354300, 12/31/2023;  1008731, 12/31/2023;  1009535, 12/31/2023;  1009538, 12/31/2023;  1012621, 12/31/2023;  1013421, 12/31/2023;  1013423, 12/31/2023;  1014132, 12/31/2023;  1014134, 12/31/2023;  1018037, 12/31/2023;  1018799, 12/31/2023;  1019769, 1/31/2024;  1020849, 1/31/2024;  1021641, 1/31/2024;  1021805, 1/31/2024;  1022415, 1/31/2024;  1022719, 1/31/2024;  1025105, 1/31/2024;  1025854, 1/31/2024;  1025950, 1/31/2024;  1026350, 1/31/2024;  1027907, 1/31/2024;  1028547, 1/31/2024;  1028799, 1/31/2024;  1029694, 1/31/2024;  1030487, 1/31/2024;  1032505, 1/31/2024;  1032717, 1/31/2024;  1033620, 1/31/2024;  1033708, 1/31/2024;  1034917, 1/31/2024;  1035640, 1/31/2024;  1036582, 1/31/2024;  1038982, 1/31/2024;  1039915, 1/31/2024;  1040816, 1/31/2024;  1041348, 1/31/2024;  1041631, 1/31/2024;  1043285, 2/29/2024;  1043350, 1/31/2024;  1048645, 2/29/2024;  1048656, 2/29/2024;  1049461, 2/29/2024;  1049465, 2/29/2024;  1050250, 2/29/2024;  1051583, 2/29/2024;  1051918, 2/29/2024;  1054135, 2/29/2024;  1054728, 2/29/2024;  1055950, 2/29/2024;  1055969, 2/29/2024;  1056752, 2/29/2024;  1057007, 2/29/2024;  1057987, 2/29/2024;  1057988, 2/29/2024;  1059824, 2/29/2024;  1060836, 2/29/2024;  1061724, 2/29/2024;  9305899, 10/31/2022;  9309166, 10/31/2022;  9339182, 11/30/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1615-2020", "product_description": "Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 90-count bottles (NDC  64727-3299-6), b) 100-count bottles (NDC 64727-3299-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: FDA analysis found product to be subpotent", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "Lot #: 099186, Exp. Date 11/2022"}, {"country": "United States", "city": "Lakewood", "address_1": "1200 Paco Way", "reason_for_recall": "Superpotent", "address_2": "", "product_quantity": "24,569 bags", "code_info": "a) A060174 01/13/2018, A060257  02/28/2018, A060692  05/31/2018, A061165  09/30/2018, A0A0143  01/31/2019, A0A0347  03/31/2019, and   A0A0424  04/30/2019 ;      b) A060027 12/31/2017", "center_classification_date": "20171220", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Fluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 mL (NDC 33600-002-10), Rx Only,  Manufactured for: Claris LifeSciences, Inc. North Brunswick, NJ 08902 By: Claris Injectables Ltd., Gujarat, India", "report_date": "20171227", "classification": "Class III", "openfda": {}, "recalling_firm": "Renaissance Lakewood, LLC", "recall_number": "D-0124-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78504", "termination_date": "20200401", "more_code_info": "", "recall_initiation_date": "20171111", "postal_code": "08701-5938", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Sellersville", "address_1": "650 Cathill Rd", "reason_for_recall": "Failed Stability Specifications: this product is below specification for preservative content.", "address_2": "", "product_quantity": "234,242 bottles", "code_info": "Lot: (Exp); V10316 (11/13),  V10317 (11/13), V10320 (11/13),  V10321 (11/13), V20086 (2/14),  V20087 (2/14), V20089 (2/14), V20093 (2/14), V20094 (2/14), V20086 (2/14), V20118 (3/14), V20119 (3/14), V20147 (3/14), V20148 (3/14), V20152 (4/14), V20154 (4/14), V20155 (4/14),  V20180 (4/14), V20181 (4/14), V20182 (4/14), V20203 (5/14), V20204 (5/14), V20233 (5/14), V20234 (5/14), V20273 (6/14), V20274 (6/14), V20275 (6/14), V20293 (8/14), V20294 (8/14), V20321 (9/14), V20322 (9/14), V20323 (9/14), V20324 (9/14), V20325 (9/14), V20326 (9/14), V20327 (9/14),  V20369 (10/14), V20370 (10/14), V20410 (11/14), V20411 (11/14), V20412 (11/14), V30009 (12/14), V30010 (12/14), V30011 (12/14), V30056 (01/15), V30120 (2/15), V30122 (2/15), V30123 (2/15), V30163 (3/15), V30164 (3/15), V30165 (3/15), V30190 (3/15), V30249 (5/15), V30250 (5/15).", "center_classification_date": "20140117", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Fluconazole Oral Suspension, 10 mg/mL, 35 ml bottle, RX only, Mfd by Cipla, Ltd., Goa, India, Dist by Teva Pharmaceuticals USA, Inc., Sellersville, PA.  NDC: 0093-5414-95.", "report_date": "20140129", "classification": "Class III", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "recall_number": "D-747-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66899", "termination_date": "20140827", "more_code_info": "", "recall_initiation_date": "20131114", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0982-2023", "product_description": "neostigmine 5 mg/5mL (1mg/mL) Syringe, Rx only,  This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6065-1", "product_quantity": "6,468 Syringes", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239285, 36-239287, Exp. 7/11/2023; 36-239456, Exp. 7/12/2023; 36-239873, Exp. 7/13/2023; 36-240994, 36-240995, 36-240996, 36-240997, Exp. 7/18/2023; 36-241447, Exp. 7/20/2023, 36-242407, 36-242408, Exp. 7/25/2023; 36-246298, Exp. 8/3/2023; 36-248998, Exp.  8/16/2023; 36-251613, Exp. 8/28/2023; 36-251781, Exp. 8/29/2023."}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89717", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "N/A", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0719-2022", "product_description": "NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00", "product_quantity": "2634 vials", "reason_for_recall": "Product found to be Sub Potent or Exceeded reconstitution time", "recall_initiation_date": "20220308", "center_classification_date": "20220329", "termination_date": "20231004", "report_date": "20220330", "code_info": "Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22"}, {"status": "Completed", "city": "Hillsborough", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88530", "recalling_firm": "Phe Inc", "address_1": "302 Meadowlands Dr", "address_2": "", "postal_code": "27278-8502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0819-2021", "product_description": "X RATED HONEY FOR MEN, packaged in 15g packets, 4 packets per box, UPC 6 13682 41232 2", "product_quantity": "15000 packets", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.", "recall_initiation_date": "20210818", "center_classification_date": "20210921", "report_date": "20210929", "code_info": "All lots, Exp. 12/2025", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88843", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0076-2022", "product_description": "Xpect First aid Extra Strength PAIN AWAY (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 Tablets/package, Packaged in 12,000 Packets/Case, Material# 111519, Mfg. for: Cintas First Aid & Safety, Mason, OH 45040 (Shipping Label)", "product_quantity": "42,394,018 tablets", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.", "recall_initiation_date": "20211013", "center_classification_date": "20211026", "termination_date": "20220328", "report_date": "20211103", "code_info": "Lot #: K-9335, AK-9419, exp. date 21-Oct; AK-9369, exp. date 21- Nov; AK-9403, exp. date 21-Dec; AK-9452, K-9455, 9455, exp. date 22-Jan; AK-9586, exp. date 22-Feb; AK-9525, AK-9526, AK-9639, exp. date 22-Mar; AK-9568, AK-9569, AK-9567, AK-9692, exp. date 22-Apr; AK-9615, exp. date 22-May; AK-9666, exp. date 22-Jun; AK-9714, K-9714, AK-9718, K-9718, 9718, exp. date 22-Jul, AK-9719, exp. date 22-Jul; AK-9771, AK-9765, AK-9769, exp. date 22-Aug; AK-9822, AK-9818, exp. date 22-Sep; AK-9860, exp. date 22-Oct; AK-9957, exp. date 22-Dec; AK-1011, K-1014, 1014, AK-9489, exp. date 23-Jan; 1055, K-1057, 1057, AK-1058, exp. date 23-Feb; AK-1108, AK-1113, K-1199, AK-1199, exp. date 23-May; AK-1240, 1240, exp. date 23-Jun; AK-9335, exp. date 10/21; AK-9406, exp. date 21-Dec; AK-1278, exp. date 23-Jul; K-1240, exp. date 23-Jun"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0042-2023", "product_description": "PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "56 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206251"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-278", "16729-279", "16729-280", "16729-281", "16729-282", "16729-283"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["40825d37-d601-2272-e063-6294a90af90d"], "spl_set_id": ["85cc7d25-414b-4b6f-a03a-48af908a16a1"], "package_ndc": ["16729-278-10", "16729-278-01", "16729-278-16", "16729-278-46", "16729-279-10", "16729-279-01", "16729-279-16", "16729-279-46", "16729-280-10", "16729-280-01", "16729-280-16", "16729-280-46", "16729-281-10", "16729-281-01", "16729-281-16", "16729-281-46", "16729-282-10", "16729-282-01", "16729-282-16", "16729-282-46", "16729-283-10", "16729-283-01", "16729-283-16", "16729-283-46"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"], "upc": ["316729282109", "316729282017"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0369-2023", "product_description": "Aripiprazole Tablets, USP 20 mg Rx Only,  packaged as, a) 30-count bottle, NDC 16729-282-10, UPC 3 16729 28210 9; b) 100-count bottle, NDC 16729-282-01, UPC 3 16729 28201 7; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India", "product_quantity": "170,448 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2100787, P2100788, Exp. Date 1/31/2024; P2104736, Exp. Date 6/30/2024; P2105492, Exp. Date 8/31/2024; P2107172, P2107175, Exp. Date 10/31/2024; P2203043, Exp. Date 5/31/2025;  b) P2104086 Exp. Date 6/30/2024, P2205370 Exp. 8/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077584"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-001", "68382-097", "68382-098", "68382-099"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE HEMIHYDRATE"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["c88d98d1-e370-4ad8-869a-603875f276cc"], "spl_set_id": ["a6bb4f0a-1555-4550-a7a4-99609674b1e7"], "package_ndc": ["68382-097-16", "68382-097-01", "68382-097-05", "68382-097-10", "68382-097-06", "68382-098-06", "68382-098-16", "68382-098-01", "68382-098-05", "68382-098-10", "68382-099-06", "68382-099-16", "68382-099-01", "68382-099-05", "68382-099-10", "68382-001-06", "68382-001-16", "68382-001-01", "68382-001-05", "68382-001-10"], "is_original_packager": [true], "upc": ["0368382098108", "0368382099105"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "78612", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0101-2018", "product_description": "Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06),   b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534", "product_quantity": "19812 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets", "recall_initiation_date": "20171120", "center_classification_date": "20171130", "termination_date": "20200901", "report_date": "20171206", "code_info": "a) Z701308, b) Z701309, c) Z701310 exp April 2019"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0831-2023", "product_description": "Neomycin & Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, 3.5 g tubes, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125387"], "brand_name": ["EYLEA"], "generic_name": ["AFLIBERCEPT"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "product_ndc": ["61755-005"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["AFLIBERCEPT"], "rxcui": ["1232154", "1232159", "2693564", "2693567"], "spl_id": ["10b670d6-52e0-4eba-953b-c839ffb98014"], "spl_set_id": ["f96cfd69-da34-41ee-90a9-610a4655cd1c"], "package_ndc": ["61755-005-02", "61755-005-55", "61755-005-01", "61755-005-54", "8231500321", "8231500335", "8231500333", "8231500334", "8231500339", "8231500347"], "is_original_packager": [true], "nui": ["N0000193543", "N0000193542"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "unii": ["15C2VL427D"]}, "product_type": "Drugs", "event_id": "94481", "recalling_firm": "Regeneron Pharmaceuticals Inc", "address_1": "777 Old Saw Mill River Rd", "address_2": "", "postal_code": "10591-6717", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0479-2024", "product_description": "EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01", "product_quantity": "251,504 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Complaints of syringe breakage", "recall_initiation_date": "20240423", "center_classification_date": "20240502", "termination_date": "20250925", "report_date": "20240508", "code_info": "Lot # 8231500321, Exp 10/31 24; 8231500335, 8231500333, 8231500334, 8231500339, 8231500347, Exp 1/30/25", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0425-2021", "product_description": "TRAVOPROST OPHTHALMIC SOLUTION, USP  0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPS", "product_quantity": "325 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RW4409"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "27 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  12022014@50, 5/31/2015; 01092015@31, 7/8/2015; 02102015@43, 8/9/2015; 03272015@42, 9/23/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (30/1/10) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1777-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0775-2018", "product_description": "Revlimid 25 mg oral cap NDC 59572-0425-21 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA201635"], "brand_name": ["TROKENDI XR"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Supernus Pharmaceuticals"], "product_ndc": ["17772-101", "17772-102", "17772-103", "17772-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["1436239", "1436245", "1437278", "1437280", "1437283", "1437285", "1437288", "1437290"], "spl_id": ["41c182e6-f5f2-bfac-e063-6294a90a547f"], "spl_set_id": ["2dc7957e-a3e5-46bb-aa66-f3250f872f5e"], "package_ndc": ["17772-102-70", "17772-102-01", "17772-102-30", "17772-102-15", "17772-102-10", "17772-102-12", "17772-102-07", "17772-103-70", "17772-103-01", "17772-103-30", "17772-103-15", "17772-103-10", "17772-103-12", "17772-103-07", "17772-104-70", "17772-104-01", "17772-104-30", "17772-104-15", "17772-104-12", "17772-104-10", "17772-104-07", "17772-101-70", "17772-101-01", "17772-101-30", "17772-101-15", "17772-101-10", "17772-101-12", "17772-101-07"], "is_original_packager": [true], "upc": ["0317772101300", "0317772102307", "0317772104301", "0317772103304"], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0570-2021", "product_description": "Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharma Solutions Winchester, KY 40391 USA Manufactured for: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA, NDC 17772-103-30", "product_quantity": "490 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1741214"}, {"status": "Terminated", "city": "San Jose", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75230", "recalling_firm": "Leiter's Compounding", "address_1": "17 Great Oaks Blvd", "address_2": "N/A", "postal_code": "95119-1359", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0014-2017", "product_description": "Lidocaine HCl 1% - Phenylephrine HCl 1.5% in Sterile Water  for Injection (Injection) 1 mL Total Volume in a 2 mL Vial (Preservative Free), Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-002-35", "product_quantity": "76,315 total units, all products", "reason_for_recall": "Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters", "recall_initiation_date": "20160920", "center_classification_date": "20161012", "termination_date": "20170503", "report_date": "20161019", "code_info": "All unexpired lots;  Expirations dates of 10/03/2016 to 12/19/2016"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-944-2013", "product_description": "CHROMIUM 4 MCG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01152013@5, 04242013@32", "more_code_info": ""}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0324-2019", "product_description": "Valsartan Tablets, USP 40 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5807-93.", "product_quantity": "160,300 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers: 3063780, 3074879, 3086684, 3086687"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0836-2019", "product_description": "Dr. King's SafeCare Rx Religious Issues, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955254027, NDC 57955-2541-2", "product_quantity": "10 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 063016B Exp. 06/19"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-537-2013", "product_description": "TL-DEX DM,  Cough Suppressant  Decongestant, Expectorant 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-067-16", "product_quantity": "2532 - 16 ounce bottles.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11AQ003  Exp 12/12."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1274-2015", "product_description": "Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only.  Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0945-01.", "product_quantity": "68,066 Bottles", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "Lot #: LM10763, Expiry: 4/30/2015; Lot #: LM10764, Expiry: 4/30/2015; Lot #: LM10765, Expiry: 4/30/2015; Lot #: LM11142, Expiry: 6/30/2015; Lot #: LM11143, Expiry: 6/30/2015; Lot #: LM11144, Expiry: 6/30/2015; Lot #: LM11255, Expiry: 7/31/2015; Lot #: LM11256, Expiry: 7/31/2015; Lot #: LM11265, Expiry: 7/31/2015; Lot #: LM11542, Expiry: 8/31/2015; Lot #: LM11543, Expiry: 8/31/2015; Lot #: LN10197, Expiry: 12/31/2015; Lot #: LN10198, Expiry: 12/31/2015; Lot #: LN10199, Expiry: 12/31/2015; Lot #: LN10200, Expiry: 12/31/2015; Lot #: LN10202, Expiry: 12/31/2015; Lot #: LN10203, Expiry: 12/31/2015; Lot #: LN10395, Expiry: 1/31/2016; Lot #: LN10396, Expiry: 1/31/2016; Lot #: LN10531, Expiry: 2/29/2016; Lot #: LN10532, Expiry: 2/29/2016; Lot #: LN10533, Expiry: 2/29/2016; Lot #: LN10534, Expiry: 2/29/2016; Lot #: LN10796, Expiry: 2/29/2016; Lot #: LN10942, Expiry: 4/30/2016."}]